Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-25-004857

Options or other derivatives

  • Chief Executive Officer acquired 530,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fortney Kristen · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +530,000 530,000 D
Loading xslF345X05/form4-02202025_090259.xml…